Cargando…
Practical Considerations for Next-Generation Adjuvant Development and Translation
Over the last several years, there has been increased interest from academia and the pharmaceutical/biotech industry in the development of vaccine adjuvants for new and emerging vaccine modalities. Despite this, vaccine adjuvant development still has some of the longest timelines in the pharmaceutic...
Autores principales: | Lykins, William R., Fox, Christopher B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385070/ https://www.ncbi.nlm.nih.gov/pubmed/37514037 http://dx.doi.org/10.3390/pharmaceutics15071850 |
Ejemplares similares
-
Immunotoxicity Considerations for Next Generation Cancer Nanomedicines
por: Hannon, Gary, et al.
Publicado: (2019) -
Clinical Quality Considerations when Using Next-Generation Sequencing (NGS) in Clinical Drug Development
por: Ménard, Timothé, et al.
Publicado: (2021) -
Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy
por: Nikitin, Nikolai, et al.
Publicado: (2023) -
Theoretical Considerations
for Next-Generation Proteomics
por: Palmblad, Magnus
Publicado: (2021) -
Translational Considerations in the Development of Intranasal Treatments for Epilepsy
por: Prentice, Richard N., et al.
Publicado: (2023)